The Endocrine Disruptor Page HomeSitemap
@

Chemical Safety Office
Evaluation and Licensing Division
Pharmaceutical and Food Safety Bureau
Ministry of Health, Labor and Welfare

Japanese

Last updated date: March 30, 2015
@

Home

 Advisory Committee

   Actions

     Scheme

     Overview

FAQs

Bisphenol A

Reports, etc.

Related reports

Links

Contact


@
Reports

Advisory Committee on Health Effects of Endocrine Disruptors
The Supplement II to the Intermediary Report
1.2.4.2

@

contents  Detailed contents  << prev  next >>

@

[Procedure for quantitative analysis]7
(i) Typical GC/MS conditions
Column: Fused silica capillary column, 0.25 mm i.d., 30 m long, film thickness 0.25 ƒÊm; phenylmethylsilicone as the liquid phase8
Column temperature: 80Ž, 3 min -> 10Ž/min -> 300Ž, 5 min
Carrier gas: Helium, total flow rate 50 ml/min, column flow rate 1.5 ml/min
Injection port temperature: 240Ž
Injection mode: Splitless
Interface temperature: 300Ž
Detection method: SIM
Monitor ions: See below.

(ii) Quantitative analysis: Inject an appropriate amount of the sample solution into the GC/MS. Check the peak areas for each PAE divided by the peak area of the internal standard against the calibration curve to obtain the concentrations of the PAEs. Use the total area of the two major peaks for DiOP and of the five major peaks for DiNP.
(iii) Calibration curve: Construct the calibration curve using the PAE peak areas, obtained by injecting an appropriate amount of the standard PAE solutions containing the internal standard, divided by the peak area for the internal standard. Use the total area of the two major peaks for DiOP and of the five major peaks for DiNP.
@

contents  Detailed contents  << prev  next >>

@

@

About links, copyright, etc.b Privacy policy

(C) 2005, 2016 Ministry of Health, Labour and Welfare, All Rights Reserved.